GNI Group Return on Equity

GNI Group (2160.T) currently reports a ROE of -13.56%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore GNI Group's ROE history and peer comparisons.

GNI Group's ROE of -13.56% is higher than the Healthcare sector average of -75.84%. That is roughly 82.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but GNI Group's current -13.56% should be judged against Healthcare norms (sector average: -75.84%) and against 2160.T's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -13.56%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for GNI Group, and consider following 2160.T for alerts when major investors trade the stock.

GNI Group is classified in the Healthcare sector. On ROE, it currently shows -13.56% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 2160.T with unrelated industries.